Review article · 2023 · Open access

In vivo gene delivery to immune cells

Jamison C. Siebart, Ching Shen Chan, Xinyi Yao, Fang‐Yi Su, Gabriel A. Kwong

Current Opinion in Biotechnology, 88, 103169 · Published 8 March 2023 · DOI 10.1016/j.copbio.2024.103169

Open PDFView at the publisherCite this paper

In brief

“In vivo gene delivery to immune cells” is a 2023 review article by Jamison C. Siebart and 4 co-authors, published in Current Opinion in Biotechnology. OpenAlex counts 12 citations as of 18 November 2026. It is open access: the full text is free to read at Current Opinion in Biotechnology.

Citations
12
Most cited in
2026 (5)
Field-weighted impact
0.36
References
84
Authors
5

Abstract

Immune cell therapies are an emerging class of living drugs that rely on the delivery of therapeutic transgenes to enhance, modulate, or restore cell function, such as those that encode for tumor-targeting receptors or replacement proteins. However, many cellular immunotherapies are autologous treatments that are limited by high manufacturing costs, typical vein-to-vein time of 3-4 weeks, and severe immune-related adverse effects. To address these issues, different classes of gene delivery vehicles are being developed to target specific immune cell subsets in vivo to address the limitations of ex vivo manufacturing, modulate therapeutic responses in situ, and reduce on- and off-target toxicity. The success of in vivo gene delivery to immune cells - which is being tested at the preclinical and clinical stages of development for the treatment of cancer, infectious diseases, and autoimmunity - is paramount for the democratization of cellular immunotherapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Siebart, J. C., Chan, C. S., Yao, X., Su, F., & Kwong, G. A. (2023). In vivo gene delivery to immune cells. Current Opinion in Biotechnology, 88, 103169. https://doi.org/10.1016/j.copbio.2024.103169

MLA 9

Siebart, Jamison C., et al. “In vivo gene delivery to immune cells.” Current Opinion in Biotechnology, vol. 88, 2023, p. 103169. https://doi.org/10.1016/j.copbio.2024.103169.

Chicago

Siebart, Jamison C., Ching Shen Chan, Xinyi Yao, Fang‐Yi Su, and Gabriel A. Kwong. 2023. “In vivo gene delivery to immune cells.” Current Opinion in Biotechnology 88: 103169. https://doi.org/10.1016/j.copbio.2024.103169.

Harvard

Siebart, J. C. et al. (2023) ‘In vivo gene delivery to immune cells’, Current Opinion in Biotechnology, 88, p. 103169. doi:10.1016/j.copbio.2024.103169.

IEEE

J. C. Siebart, C. S. Chan, X. Yao, F. Su, and G. A. Kwong, “In vivo gene delivery to immune cells,” Current Opinion in Biotechnology, vol. 88, p. 103169, 2023, doi: 10.1016/j.copbio.2024.103169.

BibTeX

@article{siebart2023vivo,
  title     = {{In vivo gene delivery to immune cells}},
  author    = {Siebart, Jamison C. and Chan, Ching Shen and Yao, Xinyi and Su, Fang‐Yi and Kwong, Gabriel A.},
  journal   = {Current Opinion in Biotechnology},
  year      = {2023},
  volume    = {88},
  pages     = {103169},
  doi       = {10.1016/j.copbio.2024.103169},
  url       = {https://doi.org/10.1016/j.copbio.2024.103169}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201511
202422
202544
202655

Its field-weighted citation impact is 0.36: it has been cited 0.36 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research

  • in vivo gene delivery
  • immune cells
  • cellular immunotherapy
  • gene carriers
  • autologous cell therapy
  • on-target off-tumor toxicity
  • cancer immunotherapy
  • autoimmunity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Siebart, J. C., Chan, C. S., Yao, X., Su, F., & Kwong, G. A. (2023). In vivo gene delivery to immune cells. Current Opinion in Biotechnology, 88, 103169. https://doi.org/10.1016/j.copbio.2024.103169

How many times has this paper been cited?

12 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Current Opinion in Biotechnology: sign in and open the PDF from this page.

Who wrote this paper?

Jamison C. Siebart, Ching Shen Chan, Xinyi Yao, Fang‐Yi Su, Gabriel A. Kwong.

What is the DOI of this paper?

10.1016/j.copbio.2024.103169, permanently at https://doi.org/10.1016/j.copbio.2024.103169. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.